Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a condensed radiation course after cervical cancer surgery be just as safe and effective?

NCT ID NCT07684508

Recruiting now Disease control Sponsor: Manni Huang Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial is testing a shorter course of radiation therapy for women who have had surgery for cervical cancer. Instead of the usual many weeks of daily treatments, participants receive a slightly higher dose each day over about three and a half weeks. The goal is to see if this approach is safe and controls the cancer as well as standard radiation, while possibly reducing side effects and making treatment more convenient.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
moderately hypofractionated intensity-modulated radiotherapy (IMRT)
What this could lead to
If successful, this shorter radiation course could become a standard option for women with cervical cancer after surgery, offering similar disease control with fewer hospital visits.
What could go wrong
This is a phase II trial with a moderate number of participants, so results are not definitive. The higher daily radiation dose may increase the risk of bowel, bladder, or blood-related side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer cervical carcinoma Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCERS HYPOFRACTIONATED RADIOTHERAPY INTENSITY-MODULATED RADIOTHERAPY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Hospital, Chinese Academy of Medical Sciences

    RECRUITING

    Beijing, Beijing Municipality, 100021, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Lang Fang Campus of Cancer Hospital, Chinese Academy of Medical Sciences

    RECRUITING

    Langfang, Hebei, 065001, China

    Contact Phone: •••-•••-••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.